Curve Therapeutics has raised £40.5 million in Series A financing to develop breakthrough cancer treatments. Curve, based in Southampton, is a BioTech company pioneering an intracellular screening platform addressing complex and challenging disease targets.  The platform, Microcycle, enables the direct discovery of biologically active molecules against targets that have been difficult to address using conventional … Continue reading Cancer-fighting BioTech Curve raises £40.5m